Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-19-001802
Filing Date
2019-02-14
Accepted
2019-02-14 16:54:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8189593_13g-a.htm SC 13G/A 135779
  Complete submission text file 0000919574-19-001802.txt   137411
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-79594 | Film No.: 19607805
SIC: 2834 Pharmaceutical Preparations

Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

EIN.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A